These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16610762)

  • 1. Oligonucleotide analogs as antiviral agents.
    Fabani MM; Turner JJ; Gait MJ
    Curr Opin Mol Ther; 2006 Apr; 8(2):108-14. PubMed ID: 16610762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
    Wagner A; Bock CT; Fechner H; Kurreck J
    Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598
    [No Abstract]   [Full Text] [Related]  

  • 3. Oligonucleotide-based strategies to inhibit human hepatitis C virus.
    Martinand-Mari C; Lebleu B; Robbins I
    Oligonucleotides; 2003; 13(6):539-48. PubMed ID: 15025918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
    Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
    Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
    Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
    J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomeric nucleic acids as antivirals.
    Mescalchin A; Restle T
    Molecules; 2011 Jan; 16(2):1271-96. PubMed ID: 21278679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonionic oligonucleotide analogs (Matagen) as anticodic agents in duplex and triplex formation.
    Ts'o PO; Aurelian L; Chang E; Miller PS
    Ann N Y Acad Sci; 1992 Oct; 660():159-77. PubMed ID: 1340119
    [No Abstract]   [Full Text] [Related]  

  • 9. Oligonucleotide-based antiviral strategies.
    Schubert S; Kurreck J
    Handb Exp Pharmacol; 2006; 173(173):261-87. PubMed ID: 16594620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic oligonucleotides with polyethylene glycol modifications.
    Winkler J
    Future Med Chem; 2015; 7(13):1721-31. PubMed ID: 26465713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA.
    Winkler J; Gilbert M; Kocourková A; Stessl M; Noe CR
    ChemMedChem; 2008 Jan; 3(1):102-10. PubMed ID: 17979170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the molecular design and applications of viral RNA-targeting antiviral modalities.
    Dai J; Jiang X; da Silva-Júnior EF; Du S; Liu X; Zhan P
    Drug Discov Today; 2024 Aug; 29(8):104074. PubMed ID: 38950729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.
    Prasad V; Hashim S; Mukhopadhyay A; Basu SK; Roy RP
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2689-96. PubMed ID: 10543748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid-based drugs against emerging zoonotic viruses.
    Wong JP
    Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides.
    Jairath S; Vargas PB; Hamlin HA; Field AK; Kilkuskie RE
    Antiviral Res; 1997 Feb; 33(3):201-13. PubMed ID: 9037376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK
    Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of 2'-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides.
    Masaki Y; Iriyama Y; Nakajima H; Kuroda Y; Kanaki T; Furukawa S; Sekine M; Seio K
    Nucleic Acid Ther; 2018 Oct; 28(5):307-311. PubMed ID: 30020852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.